Loading...
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
Current strategies for the treatment of hereditary angioedema (HAE) include targeted inhibition or antagonism of the contact system, which is dysregulated in HAE patients by a C1 esterase inhibitor deficiency. Ecallantide, a plasma kallikrein inhibitor, and icatibant, a selective bradykinin-2 recept...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
World Allergy Organization
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3666151/ https://ncbi.nlm.nih.gov/pubmed/23282868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/1939-4551-3-S3-S34 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|